Dilated cardiomyopathy and impaired cardiac hypertrophic response to angiotensin II in mice lacking FGF-2. - Wikidata - awgldk - TriplyDB

Dilated cardiomyopathy and impaired cardiac hypertrophic response to angiotensin II in mice lacking FGF-2.

Dilated cardiomyopathy and impaired cardiac hypertrophic response to angiotensin II in mice lacking FGF-2.

http://www.wikidata.org/entity/Q36169934

about

Pathophysiological roles of FGF signaling in the heart Fibroblast growth factor receptor 1 signaling in adult cardiomyocytes increases contractility and results in a hypertrophic cardiomyopathy Roles of FGF Signals in Heart Development, Health, and Disease The fibrosis-cell death axis in heart failure High molecular weight fibroblast growth factor-2 in the human heart is a potential target for prevention of cardiac remodeling Intramyocardial fibroblast myocyte communication.FGF-2 controls the differentiation of resident cardiac precursors into functional cardiomyocytes.Fibroblast deletion of ROCK2 attenuates cardiac hypertrophy, fibrosis, and diastolic dysfunction Connexin43-dependent mechanism modulates renin secretion and hypertension Fibroblast Growth Factor 2 Mediates Isoproterenol-induced Cardiac Hypertrophy through Activation of the Extracellular Regulated Kinase.Changes in cardiac heparan sulfate proteoglycan expression and streptozotocin-induced diastolic dysfunction in rats Fibroblast growth factor 2 is an essential cardioprotective factor in a closed-chest model of cardiac ischemia-reperfusion injury Protective and Therapeutic Effects of Chinese Medicine Formula Jiajian Yunvjian on Experimental Cardiac Remodeling after Myocardial Infarction Induced by Coronary Artery Ligation.Modulation of cardiac fibrosis by Krüppel-like factor 6 through transcriptional control of thrombospondin 4 in cardiomyocytes.Fibroblast growth factor-2 regulates myocardial infarct repair: effects on cell proliferation, scar contraction, and ventricular function Endothelial fibroblast growth factor receptor signaling is required for vascular remodeling following cardiac ischemia-reperfusion injury The plasma membrane calcium ATPase 4 signalling in cardiac fibroblasts mediates cardiomyocyte hypertrophy Pathways involved in the transition from hypertension to hypertrophy to heart failure. Treatment strategies.Stemming heart failure with cardiac- or reprogrammed-stem cells.Biological functions of the low and high molecular weight protein isoforms of fibroblast growth factor-2 in cardiovascular development and disease.FGF2 modulates cardiac remodeling in an isoform- and sex-specific manner.Cardiac development and physiology are modulated by FGF2 in an isoform- and sex-specific manner.Multiple faces of fibroblast growth factor-23 Shared circuitry: developmental signaling cascades regulate both embryonic and adult coronary vasculature.Cellular Interplay between Cardiomyocytes and Nonmyocytes in Cardiac Remodeling.Cardiac actions of fibroblast growth factor 23.Role of integrins in mediating cardiac fibroblast-cardiomyocyte cross talk: a dynamic relationship in cardiac biology and pathophysiology.Serial killer: angiotensin drives cardiac hypertrophy via TGF-beta1.Myocardial gene expression of matched hibernating and control tissue from patients with ischemic left ventricular dysfunction.Blood Pressure Control by a Secreted FGFBP1 (Fibroblast Growth Factor-Binding Protein).Physiologic, Pathologic, and Therapeutic Paracrine Modulation of Cardiac Excitation-Contraction Coupling.Densification of Type I Collagen Matrices as a Model for Cardiac Fibrosis.Paracrine effects of hypoxic fibroblast-derived factors on the MPT-ROS threshold and viability of adult rat cardiac myocytes.Tyrosine kinase inhibitor BIBF1000 does not hamper right ventricular pressure adaptation in rats.Exploring the Clinical Relevance of Providing Increased Removal of Large Middle Molecules.Calcitriol downregulates fibroblast growth factor receptor 1 through histone deacetylase activation in HL-1 atrial myocytes.Triggering Endogenous Cardiac Repair and Regeneration via Extracellular Vesicle-Mediated Communication Telocinobufagin, a Novel Cardiotonic Steroid, Promotes Renal Fibrosis via Na⁺/K⁺-ATPase Profibrotic Signaling Pathways

P2860

Q26853186-083B9F72-F3AD-4CC5-98FD-DA18627EB4A1 Q27342077-ADBCB44B-F784-4B4C-AC03-D66FFE60BE8E Q28072691-57543A7F-9DBE-4476-895A-7F2E0A554D03 Q28076570-CFEDD914-D81E-404E-ADBD-477D441672C3 Q31161236-5EC5CC90-C257-436C-9C48-046556C93F62 Q33586605-0A185827-6786-4BB1-A157-6782B34381F1 Q33842934-DA8B087D-2A17-49CC-B441-2984A4122AE5 Q33877795-BE0A8B40-78EE-449A-A84C-BCEB5172E740 Q34312749-2F66781E-4B53-4C14-8716-1B1FA7F7377B Q34517887-BAE64AD2-EB51-4C5A-9D70-043364DB463D Q34999815-9B60697A-9647-4C4F-A79D-AE21CD5CD358 Q35294164-169CF0F5-5489-4276-9909-2BB65839CC02 Q35818138-661DFC3E-D01C-488A-93F4-A84E37D9C6B8 Q35966000-9C0AA477-5006-4690-A5E3-62F5E0DF6310 Q36095572-366E677A-43E8-4697-A1B2-BF7F7E66B988 Q36699574-0019E2BF-38D3-4D98-92BE-E7F0ACA46EE5 Q36764483-8A218FFF-5324-45C8-A480-0CF49B62DE42 Q36995248-322381A4-DB5E-47A0-9299-1872D09638B2 Q37255265-91FE34C3-36E8-4062-A7A3-A21DD04AC539 Q37261502-596F1545-3FAE-4502-A471-3593B86223D5 Q37307785-A96023A4-B054-4DA0-92A3-CDB1D48789CF Q37307814-BACE3BAF-63D4-46BF-BBBD-1AE91FD758BE Q37312020-17A17DE7-CD24-4884-9566-929825F72136 Q37380465-87C55DB6-6338-4904-A834-8E61CA73063E Q38509926-BB01EAE8-AF12-4149-A61D-A0626B15E358 Q38977291-81939D38-1D0F-44F8-9BC8-5EC93D605181 Q39045116-C9A4412F-BAB8-4E71-957A-138D0EE3F802 Q39737699-08A9A865-5E4C-4F9A-A036-E2B04CBAFC7D Q44563021-84AA7F21-A08C-4A9B-81EC-4DCD67F3AB66 Q46257674-9ADD7B33-3BD7-4443-9253-068D4BD59754 Q47200001-3998FB4B-9FF7-4E8F-9CAE-D8380CFFAE85 Q47704324-CFED8D24-AC43-4923-8D3D-C78EAB27DFC9 Q47776031-FA05E5D0-E85F-450C-A39D-15CF008A6573 Q51501927-B393AE4E-4039-4C93-A96E-8E1C9E9D18E3 Q52673327-DA7E1018-6561-45F0-A2D9-B977EA31E6D8 Q54978780-6EE6534C-A808-41B0-B563-9EC681A16EA8 Q58573582-7EB96222-084F-4474-830A-B10BC82B4898 Q58692613-DC8AB32F-9964-4281-8E37-6EECDABD4EAE

P2860

Dilated cardiomyopathy and impaired cardiac hypertrophic response to angiotensin II in mice lacking FGF-2.

http://www.wikidata.org/entity/Q36169934

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

2001年论文

@zh

2001年论文

@zh-cn

name

Dilated cardiomyopathy and imp ...... nsin II in mice lacking FGF-2.

@ast

Dilated cardiomyopathy and imp ...... nsin II in mice lacking FGF-2.

@en

type

label

Dilated cardiomyopathy and imp ...... nsin II in mice lacking FGF-2.

@ast

Dilated cardiomyopathy and imp ...... nsin II in mice lacking FGF-2.

@en

prefLabel

Dilated cardiomyopathy and imp ...... nsin II in mice lacking FGF-2.

@ast

Dilated cardiomyopathy and imp ...... nsin II in mice lacking FGF-2.

@en

P1433

Q36169934-2D9C0179-9530-400A-ACE0-B2C737AB330B

P1476

Q36169934-82F27B73-074F-4F0E-B804-56C7E099BBA6

P2093

Q36169934-0C08F377-CA59-4B20-90AD-B2300BA53172

Q36169934-0DE3CEF3-DD8F-4BD5-8B28-BB4819CA5F7D

Q36169934-1399D01E-4501-418F-A838-B54E8FC1A223

Q36169934-2F92E07E-A69B-49CA-BC8D-9009AA6868B3

Q36169934-40917662-476D-475C-BE44-03425271BBE9

Q36169934-66137CE9-E338-4259-8831-1772FB74E912

Q36169934-A1B42299-7562-4A20-A062-2D9D27C5A13F

Q36169934-F96F6CF6-3A31-41BF-9EF4-A52125A90157

P2860

Q36169934-019A3A36-DE3C-4400-8900-244334293F42

Q36169934-10D93013-D619-46D3-B458-9DCD1157E398

Q36169934-20B5B882-4D14-4EC7-A543-A02F0D382C7E

Q36169934-3215DE26-E9A1-4708-BD77-83D48DF9A7A8

Q36169934-36E9F1E6-F69B-4627-B04D-3F597488008C

Q36169934-4D1A3352-2AED-490A-8AB5-9009D8752BA6

Q36169934-58552EA7-2C38-4ECD-82D3-BE69AE85100A

Q36169934-81B48677-DA5E-4305-99E2-0DB2D2E37D1A

Q36169934-83B94175-FB35-4F5E-9AD6-1F5F730AE220

Q36169934-847913B8-AA5A-40C1-BAEF-089035A92C20

P304

Q36169934-11B7EFFA-BD49-4FB7-BEE7-6C4331AB62AE

P31

Q36169934-4062BF71-1F20-41D5-9536-1E94A2477AB3

P356

Q36169934-FC80B969-8FF2-4458-B2E2-806BA3537DE5

P407

Q36169934-09A9BB9E-6611-4E1E-AEEB-24DFBDF81B10

P433

Q36169934-EBDD67B2-0D29-46AD-8854-294A5508DE80

P478

Q36169934-6C2CA225-463F-4CFE-8D20-DD3D8B8CA78B

P577

Q36169934-F4C6B43B-17B1-4DF9-A2CD-40E0693E69DB

P698

Q36169934-423934FF-4904-4969-AE05-D04A0EC09831

P932

Q36169934-DB35188A-97E2-4A58-8C8A-96DEED80F098

P356

P1433

Journal of Clinical Investigation

P1476

Dilated cardiomyopathy and imp ...... nsin II in mice lacking FGF-2.

@en

P2093

A Foletti

http://www.w3.org/2001/XMLSchema#string

C Pellieux

http://www.w3.org/2001/XMLSchema#string

F Beermann

http://www.w3.org/2001/XMLSchema#string

G Peduto

http://www.w3.org/2001/XMLSchema#string

H R Brunner

http://www.w3.org/2001/XMLSchema#string

J F Aubert

http://www.w3.org/2001/XMLSchema#string

J Nussberger

http://www.w3.org/2001/XMLSchema#string

T Pedrazzini

http://www.w3.org/2001/XMLSchema#string

P2860

Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2

Fibroblast growth factor-2 mediates pressure-induced hypertrophic response

High and low molecular weight fibroblast growth factor-2 increase proliferation of neonatal rat cardiac myocytes but have differential effects on binucleation and nuclear morphology. Evidence for both paracrine and intracrine actions of fibroblast g

Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype

Cardiac hypertrophy: sorting out the circuitry.

Communication between myocytes and fibroblasts in cardiac remodeling in angiotensin chimeric mice

Impaired cerebral cortex development and blood pressure regulation in FGF-2-deficient mice

Peptide growth factors can provoke "fetal" contractile protein gene expression in rat cardiac myocytes.

Role of transiently altered sarcolemmal membrane permeability and basic fibroblast growth factor release in the hypertrophic response of adult rat ventricular myocytes to increased mechanical activity in vitro

Fibroblast growth factor 2 control of vascular tone.

P304

1843-1851

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI13627

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P577

2001-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11748268

http://www.w3.org/2001/XMLSchema#string

P932

209469

http://www.w3.org/2001/XMLSchema#string